Shares of BIO-key International, Inc. (NASDAQ:BKYI – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.09 and traded as low as $0.69. BIO-key International shares last traded at $0.72, with a volume of 17,640 shares.
BIO-key International Price Performance
The stock has a market capitalization of $2.24 million, a P/E ratio of -0.32 and a beta of 0.49. The company has a current ratio of 0.78, a quick ratio of 0.71 and a debt-to-equity ratio of 0.63. The company has a fifty day simple moving average of $0.97 and a two-hundred day simple moving average of $1.08.
BIO-key International (NASDAQ:BKYI – Get Free Report) last posted its earnings results on Thursday, March 27th. The technology company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.18). BIO-key International had a negative net margin of 72.53% and a negative return on equity of 3,124.77%. The business had revenue of $1.46 million during the quarter, compared to analyst estimates of $2.29 million.
BIO-key International Company Profile
BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.
Read More
- Five stocks we like better than BIO-key International
- About the Markup Calculator
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- What is the Dogs of the Dow Strategy? Overview and Examples
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- How to Effectively Use the MarketBeat Ratings Screener
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.